Home

Abstracts List

 Library
Previous  List

Fraxiparine® (nadroparin)

 Next  List
                      For viewing the abstract double click on the title below:
1) Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.

2)Nadroparin calcium. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders.

3) Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.

4) Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire Transluminale.

5) [Efficacy and tolerance of Fraxiparine in the prevention of deep vein thrombosis in general surgery performed with medullar conduction anesthesia].

6) [Fraxiparin and prevention of left ventricular thrombosis in  non-thrombolyzed myocardial infarction. FRATIV Study].

7) Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.

8) Use of single dose low-molecular-weight heparin in long hemodialysis.

9) Pilot study of low-molecular-weight heparin in the treatment of acute ischemic stroke.

10) [Efficacy and tolerability of fraxiparine in the prevention of thromboembolic complications in oncologic thoracic surgery]